Skip to main content
. 2019 Jun 25;140(4):270–279. doi: 10.1161/CIRCULATIONAHA.118.038814

Figure 5.

Figure 5.

Estimates for genetic association between calcium channel blockers and diverticulosis risk derived from PheWAS analyses in the UK Biobank and BioVU, respectively, and their fixed-effects pooled estimate. BioVU indicates Vanderbilt University Biobank; GRS, genetic risk score; and PheWAS, phenome-wide association study.